Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
United States | Publication | January 19, 2022
In another blow to the cooperative spirit between private businesses and federal regulators, the Federal Trade Commission (the “Commission”) issued its “Statement of the Commission on Use of Prior Approval Provisions in Merger Orders,” (the “Policy”) on October 25, 2021, announcing that it now intends to “routinely require[e] merging parties subject to a Commission order to obtain prior approval before closing any future transaction affecting each relevant market for which a violation was alleged . . . for a minimum of ten years.” Companies willing to enter into a consent decree with the Commission will now be required to subject future transactions to Commission review and approval without any of the statutorily prescribed rules governing merger review under the Hart-Scott-Rodino (“HSR”) Act; meaning the Commission can now review—and block—such transactions without complying with any statutory timeframe or substantive standards.
Special thanks to Tim Chung (New York) for his assistance in the preparation of this content.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023